Interventional Oncology Market Size, Share, and Outlook, H2-2025 Report- By Product ( Embolization Devices, Ablation Devices, Support Devices), By Procedure (Thermal Tumor Ablation, Non-Thermal Tumor Ablation, Transcatheter Arterial Chemoembolization, Tra
Description
Interventional Oncology Market Outlook
The global Interventional Oncology Market Size is valued at $2.6 Billion in 2025 and is forecast to reach $4.7 Billion in 2032 at a CAGR of 8.8%.
The Interventional Oncology Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on Interventional Oncology Market segments across 22 countries from 2021 to 2032. Key segments covered include By Product ( Embolization Devices, Ablation Devices, Support Devices), By Procedure (Thermal Tumor Ablation, Non-Thermal Tumor Ablation, Transcatheter Arterial Chemoembolization, Transcatheter Arterial Radioembolizatio, Transcatheter Arterial Embolization), By Disease (Liver Cancer, Lung Cancer, Bone Metastasis, Kidney Cancer, Breast Cancer, Prostate Cancer, Others), By End-User (Hospitals, Ambulatory Surgery Centers, Research & Academic Institutes), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
Interventional Oncology Market Insights, 2025
The interventional oncology market is an emerging pillar of cancer treatment, focusing on image-guided, minimally invasive procedures such as ablation, embolization, and targeted drug delivery. These techniques offer shorter recovery times, fewer side effects, and the potential to treat inoperable tumors. The market’s growth is fueled by rising cancer incidence, increasing availability of advanced imaging modalities, and growing demand for palliative care solutions. Hospitals and cancer centers are investing in hybrid operating rooms to facilitate integrated interventional oncology procedures. Technological innovations, including microwave ablation and drug-eluting beads, are expanding treatment options and improving patient outcomes. Interventional oncology is also being integrated with systemic therapies to achieve better disease control. Training programs for interventional radiologists are expanding globally, boosting procedural adoption. The increasing alignment of these techniques with precision medicine principles ensures their growing role in comprehensive cancer care strategies.
Five Trends Shaping the Global Interventional Oncology Market in 2025 and Beyond
The global Interventional Oncology Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the Interventional Oncology Industry?
The Interventional Oncology Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, Interventional Oncology Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
Interventional Oncology Market Segment Insights
The Interventional Oncology Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Product ( Embolization Devices, Ablation Devices, Support Devices), By Procedure (Thermal Tumor Ablation, Non-Thermal Tumor Ablation, Transcatheter Arterial Chemoembolization, Transcatheter Arterial Radioembolizatio, Transcatheter Arterial Embolization), By Disease (Liver Cancer, Lung Cancer, Bone Metastasis, Kidney Cancer, Breast Cancer, Prostate Cancer, Others), By End-User (Hospitals, Ambulatory Surgery Centers, Research & Academic Institutes). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
Interventional Oncology Industry Value Chain
The chapter identifies potential companies and their operations across the global Interventional Oncology Industry ecosystem. It assists decision-makers in evaluating global Interventional Oncology Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the Interventional Oncology Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific Interventional Oncology Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for Interventional Oncology Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States Interventional Oncology Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Interventional Oncology Market.
Europe Interventional Oncology Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for Interventional Oncology Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for Interventional Oncology Industry competitiveness. The report analyses the key Interventional Oncology Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American Interventional Oncology Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international Interventional Oncology Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa Interventional Oncology Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for Interventional Oncology Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How Interventional Oncology Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the Interventional Oncology Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes ABK Biomedical Inc, Accuray Inc, Alpinion Medical Systems Co. Ltd, AngioDynamics Inc, Baylis Medical Company Inc, Becton, Dickinson and Company, Boston Scientific Corp, Cook Medical LLC, Endo Shape Inc, Guerbet SA, HealthTronics Inc, IceCure Medical Ltd, IMBiotechnologies Ltd, Instylla Inc, Interface Biomaterials B.V., Johnson & Johnson, Medtronic Inc, MedWaves Inc, Merit Medical Systems Inc, Mermaid Medical A/S, Monteris Medical Inc, Profound Medical corp, Sanarus Medical Inc, Shape Memory Medical Inc, Sirtex Medical Ltd, Teleflex Inc, Terumo Corp, Trisalus Lifesciences Corp, Trod Medical Ltd. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
Interventional Oncology Market Scope
Leading Segments
By Product
Embolization DevicesRadioembolic Agents Non-Radio embolic Agents
Ablation DevicesRadiofrequency (RF) Ablation Devices Microwave Ablation Devices Cryoablation Devices Others
Support DevicesMicrocatheters Guidewires
By Procedure
Thermal Tumor Ablation
Non-Thermal Tumor Ablation
Transcatheter Arterial Chemoembolization
Transcatheter Arterial Radioembolizatio
Transcatheter Arterial Embolization
By Disease
Liver Cancer
Lung Cancer
Bone Metastasis
Kidney Cancer
Breast Cancer
Prostate Cancer
Others
By End-User
Hospitals
Ambulatory Surgery Centers
Research & Academic Institutes
Leading Companies
ABK Biomedical Inc
Accuray Inc
Alpinion Medical Systems Co. Ltd
AngioDynamics Inc
Baylis Medical Company Inc
Becton, Dickinson and Company
Boston Scientific Corp
Cook Medical LLC
Endo Shape Inc
Guerbet SA
HealthTronics Inc
IceCure Medical Ltd
IMBiotechnologies Ltd
Instylla Inc
Interface Biomaterials B.V.
Johnson & Johnson
Medtronic Inc
MedWaves Inc
Merit Medical Systems Inc
Mermaid Medical A/S
Monteris Medical Inc
Profound Medical corp
Sanarus Medical Inc
Shape Memory Medical Inc
Sirtex Medical Ltd
Teleflex Inc
Terumo Corp
Trisalus Lifesciences Corp
Trod Medical Ltd
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report Make informed decisions with 12-year forecasts across 22 countries and multiple market segments. Evaluate regulatory impacts, sustainability trends, and disruptive technologies shaping the chemicals industry. Gain insights into the competitive landscape, including company profiles, financials, and strategic moves. Build an integrated understanding of the chemicals ecosystem across upstream, midstream, and downstream operations. Leverage insights on circular economy initiatives, digitalization, and carbon-neutral strategies driving the next decade. Assess risks and opportunities with scenario-based forecasts tailored to different growth conditions. Access the report in multiple formats (PDF, Excel, PPT) for easier integration into strategic planning.
The global Interventional Oncology Market Size is valued at $2.6 Billion in 2025 and is forecast to reach $4.7 Billion in 2032 at a CAGR of 8.8%.
The Interventional Oncology Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on Interventional Oncology Market segments across 22 countries from 2021 to 2032. Key segments covered include By Product ( Embolization Devices, Ablation Devices, Support Devices), By Procedure (Thermal Tumor Ablation, Non-Thermal Tumor Ablation, Transcatheter Arterial Chemoembolization, Transcatheter Arterial Radioembolizatio, Transcatheter Arterial Embolization), By Disease (Liver Cancer, Lung Cancer, Bone Metastasis, Kidney Cancer, Breast Cancer, Prostate Cancer, Others), By End-User (Hospitals, Ambulatory Surgery Centers, Research & Academic Institutes), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
Interventional Oncology Market Insights, 2025
The interventional oncology market is an emerging pillar of cancer treatment, focusing on image-guided, minimally invasive procedures such as ablation, embolization, and targeted drug delivery. These techniques offer shorter recovery times, fewer side effects, and the potential to treat inoperable tumors. The market’s growth is fueled by rising cancer incidence, increasing availability of advanced imaging modalities, and growing demand for palliative care solutions. Hospitals and cancer centers are investing in hybrid operating rooms to facilitate integrated interventional oncology procedures. Technological innovations, including microwave ablation and drug-eluting beads, are expanding treatment options and improving patient outcomes. Interventional oncology is also being integrated with systemic therapies to achieve better disease control. Training programs for interventional radiologists are expanding globally, boosting procedural adoption. The increasing alignment of these techniques with precision medicine principles ensures their growing role in comprehensive cancer care strategies.
Five Trends Shaping the Global Interventional Oncology Market in 2025 and Beyond
The global Interventional Oncology Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the Interventional Oncology Industry?
The Interventional Oncology Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, Interventional Oncology Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
Interventional Oncology Market Segment Insights
The Interventional Oncology Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Product ( Embolization Devices, Ablation Devices, Support Devices), By Procedure (Thermal Tumor Ablation, Non-Thermal Tumor Ablation, Transcatheter Arterial Chemoembolization, Transcatheter Arterial Radioembolizatio, Transcatheter Arterial Embolization), By Disease (Liver Cancer, Lung Cancer, Bone Metastasis, Kidney Cancer, Breast Cancer, Prostate Cancer, Others), By End-User (Hospitals, Ambulatory Surgery Centers, Research & Academic Institutes). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
Interventional Oncology Industry Value Chain
The chapter identifies potential companies and their operations across the global Interventional Oncology Industry ecosystem. It assists decision-makers in evaluating global Interventional Oncology Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the Interventional Oncology Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific Interventional Oncology Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for Interventional Oncology Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States Interventional Oncology Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Interventional Oncology Market.
Europe Interventional Oncology Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for Interventional Oncology Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for Interventional Oncology Industry competitiveness. The report analyses the key Interventional Oncology Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American Interventional Oncology Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international Interventional Oncology Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa Interventional Oncology Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for Interventional Oncology Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How Interventional Oncology Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the Interventional Oncology Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes ABK Biomedical Inc, Accuray Inc, Alpinion Medical Systems Co. Ltd, AngioDynamics Inc, Baylis Medical Company Inc, Becton, Dickinson and Company, Boston Scientific Corp, Cook Medical LLC, Endo Shape Inc, Guerbet SA, HealthTronics Inc, IceCure Medical Ltd, IMBiotechnologies Ltd, Instylla Inc, Interface Biomaterials B.V., Johnson & Johnson, Medtronic Inc, MedWaves Inc, Merit Medical Systems Inc, Mermaid Medical A/S, Monteris Medical Inc, Profound Medical corp, Sanarus Medical Inc, Shape Memory Medical Inc, Sirtex Medical Ltd, Teleflex Inc, Terumo Corp, Trisalus Lifesciences Corp, Trod Medical Ltd. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
Interventional Oncology Market Scope
Leading Segments
By Product
Embolization Devices
Ablation Devices
Support Devices
By Procedure
Thermal Tumor Ablation
Non-Thermal Tumor Ablation
Transcatheter Arterial Chemoembolization
Transcatheter Arterial Radioembolizatio
Transcatheter Arterial Embolization
By Disease
Liver Cancer
Lung Cancer
Bone Metastasis
Kidney Cancer
Breast Cancer
Prostate Cancer
Others
By End-User
Hospitals
Ambulatory Surgery Centers
Research & Academic Institutes
Leading Companies
ABK Biomedical Inc
Accuray Inc
Alpinion Medical Systems Co. Ltd
AngioDynamics Inc
Baylis Medical Company Inc
Becton, Dickinson and Company
Boston Scientific Corp
Cook Medical LLC
Endo Shape Inc
Guerbet SA
HealthTronics Inc
IceCure Medical Ltd
IMBiotechnologies Ltd
Instylla Inc
Interface Biomaterials B.V.
Johnson & Johnson
Medtronic Inc
MedWaves Inc
Merit Medical Systems Inc
Mermaid Medical A/S
Monteris Medical Inc
Profound Medical corp
Sanarus Medical Inc
Shape Memory Medical Inc
Sirtex Medical Ltd
Teleflex Inc
Terumo Corp
Trisalus Lifesciences Corp
Trod Medical Ltd
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report
Table of Contents
191 Pages
- 1. Table of Contents
- List of Figures and Tables
- 2. Executive Summary
- 2.1 Key Highlights
- 2.1.1 Interventional Oncology Market Size Outlook, 2018-2024 and 2025-2032
- 2.1.2 Largest Interventional Oncology Market Types and Applications
- 2.1.3 Fastest Growing Segments
- 2.1.4 Potential Markets
- 2.1.5 Market Concentration
- 2.2 Market Scope and Segmentation
- 2.2.1 Market Scope- Segments
- 2.2.2 Market Scope- Countries
- 2.2.3 Macroeconomic and Demographic Outlook
- 2.2.4 Abbreviations
- 2.2.5 Units and Currency Conversions
- 3. Research Methodology
- 3.1 Primary Research Surveys
- 3.2 Secondary Data Sources
- 3.3 Data Triangulation
- 3.4 Forecast Methodology
- 3.5 Assumptions and Limitations
- 4. Introduction to Global Interventional Oncology Market in 2025
- 4.1 Industry Panorama
- 4.2 Leading Companies Profiled in the Study
- 4.3 Asia Pacific Markets offer Robust Market Prospects for New Entrants
- 4.4 Market Dynamics
- 4.4.1 Market Dynamics- Trends and Drivers
- 4.4.2 Market Dynamics- Opportunities and Challenges
- 4.5 Regional Analysis
- 4.6 Porter’s Five Force Analysis
- 4.6.1 Intensity of Competitive Rivalry
- 4.6.2 Threat of New Entrants
- 4.6.3 Threat of Substitutes
- 4.6.4 Bargaining Power of Buyers
- 4.6.5 Bargaining Power of Suppliers
- 4.7 Interventional Oncology Market Industry Value Chain Analysis
- 4.7.1 Stage of Value Chain
- 4.7.2 Key Activities of Companies
- 4.7.3 Companies Included in Each Stage
- 4.7.4 Key Insights
- 5. Interventional Oncology Market Outlook to 2032
- 5.1 Market Size Forecast by Type, 2021-2024 and 2025-2032
- 5.2 Market Size Forecast by Application, 2021-2024 and 2024-2032
- 5.3 Market Size Forecast by Geography, 2021-2024 and 2024-2032
- By Product
- Embolization Devices
- -Radioembolic Agents
- -Non-Radio embolic Agents
- Ablation Devices
- -Radiofrequency (RF) Ablation Devices
- -Microwave Ablation Devices
- -Cryoablation Devices
- -Others
- Support Devices
- -Microcatheters
- -Guidewires
- By Procedure
- Thermal Tumor Ablation
- Non-Thermal Tumor Ablation
- Transcatheter Arterial Chemoembolization
- Transcatheter Arterial Radioembolizatio
- Transcatheter Arterial Embolization
- By Disease
- Liver Cancer
- Lung Cancer
- Bone Metastasis
- Kidney Cancer
- Breast Cancer
- Prostate Cancer
- Others
- By End-User
- Hospitals
- Ambulatory Surgery Centers
- Research & Academic Institutes
- 6. Global Interventional Oncology Market Outlook across Growth Scenarios
- 6.1 Low Growth Scenario
- 6.2 Base/Reference Case
- 6.3 High Growth Scenario
- 6. North America Interventional Oncology Market Size Outlook
- 6.1 Key Market Statistics, 2024
- 6.2 North America Interventional Oncology Market Trends and Growth Opportunities
- 6.2.1 North America Interventional Oncology Market Outlook by Type
- 6.2.2 North America Interventional Oncology Market Outlook by Application
- 6.3 North America Interventional Oncology Market Outlook by Country
- 6.3.1 The US Interventional Oncology Market Outlook, 2021- 2032
- 6.3.2 Canada Interventional Oncology Market Outlook, 2021- 2032
- 6.3.3 Mexico Interventional Oncology Market Outlook, 2021- 2032
- 7. Europe Interventional Oncology Market Size Outlook
- 7.1 Key Market Statistics, 2024
- 7.2 Europe Interventional Oncology Market Trends and Growth Opportunities
- 7.2.1 Europe Interventional Oncology Market Outlook by Type
- 7.2.2 Europe Interventional Oncology Market Outlook by Application
- 7.3 Europe Interventional Oncology Market Outlook by Country
- 7.3.2 Germany Interventional Oncology Market Outlook, 2021- 2032
- 7.3.3 France Interventional Oncology Market Outlook, 2021- 2032
- 7.3.4 The UK Interventional Oncology Market Outlook, 2021- 2032
- 7.3.5 Spain Interventional Oncology Market Outlook, 2021- 2032
- 7.3.6 Italy Interventional Oncology Market Outlook, 2021- 2032
- 7.3.7 Russia Interventional Oncology Market Outlook, 2021- 2032
- 7.3.8 Rest of Europe Interventional Oncology Market Outlook, 2021- 2032
- 8. Asia Pacific Interventional Oncology Market Size Outlook
- 8.1 Key Market Statistics, 2024
- 8.2 Asia Pacific Interventional Oncology Market Trends and Growth Opportunities
- 8.2.1 Asia Pacific Interventional Oncology Market Outlook by Type
- 8.2.2 Asia Pacific Interventional Oncology Market Outlook by Application
- 8.3 Asia Pacific Interventional Oncology Market Outlook by Country
- 8.3.1 China Interventional Oncology Market Outlook, 2021- 2032
- 8.3.2 India Interventional Oncology Market Outlook, 2021- 2032
- 8.3.3 Japan Interventional Oncology Market Outlook, 2021- 2032
- 8.3.4 South Korea Interventional Oncology Market Outlook, 2021- 2032
- 8.3.5 Australia Interventional Oncology Market Outlook, 2021- 2032
- 8.3.6 South East Asia Interventional Oncology Market Outlook, 2021- 2032
- 8.3.7 Rest of Asia Pacific Interventional Oncology Market Outlook, 2021- 2032
- 9. South America Interventional Oncology Market Size Outlook
- 9.1 Key Market Statistics, 2024
- 9.2 South America Interventional Oncology Market Trends and Growth Opportunities
- 9.2.1 South America Interventional Oncology Market Outlook by Type
- 9.2.2 South America Interventional Oncology Market Outlook by Application
- 9.3 South America Interventional Oncology Market Outlook by Country
- 9.3.1 Brazil Interventional Oncology Market Outlook, 2021- 2032
- 9.3.2 Argentina Interventional Oncology Market Outlook, 2021- 2032
- 9.3.3 Rest of South and Central America Interventional Oncology Market Outlook, 2021- 2032
- 10. Middle East and Africa Interventional Oncology Market Size Outlook
- 10.1 Key Market Statistics, 2024
- 10.2 Middle East and Africa Interventional Oncology Market Trends and Growth Opportunities
- 10.2.1 Middle East and Africa Interventional Oncology Market Outlook by Type
- 10.2.2 Middle East and Africa Interventional Oncology Market Outlook by Application
- 10.3 Middle East and Africa Interventional Oncology Market Outlook by Country
- 10.3.1 Saudi Arabia Interventional Oncology Market Outlook, 2021- 2032
- 10.3.2 The UAE Interventional Oncology Market Outlook, 2021- 2032
- 10.3.3 Rest of Middle East Interventional Oncology Market Outlook, 2021- 2032
- 10.3.4 South Africa Interventional Oncology Market Outlook, 2021- 2032
- 10.3.5 Egypt Interventional Oncology Market Outlook, 2021- 2032
- 10.3.6 Rest of Africa Interventional Oncology Market Outlook, 2021- 2032
- 11. Company Profiles
- 11.1 Leading 10 Companies
- ABK Biomedical Inc
- Accuray Inc
- Alpinion Medical Systems Co. Ltd
- AngioDynamics Inc
- Baylis Medical Company Inc
- Becton, Dickinson and Company
- Boston Scientific Corp
- Cook Medical LLC
- Endo Shape Inc
- Guerbet SA
- HealthTronics Inc
- IceCure Medical Ltd
- IMBiotechnologies Ltd
- Instylla Inc
- Interface Biomaterials B.V.
- Johnson & Johnson
- Medtronic Inc
- MedWaves Inc
- Merit Medical Systems Inc
- Mermaid Medical A/S
- Monteris Medical Inc
- Profound Medical corp
- Sanarus Medical Inc
- Shape Memory Medical Inc
- Sirtex Medical Ltd
- Teleflex Inc
- Terumo Corp
- Trisalus Lifesciences Corp
- Trod Medical Ltd
- 11.2 Overview
- 11.3 Products and Services
- 11.4 SWOT Profile
- 12. Appendix
- 12.1 Subscription Options
- 12.2 Customization Options
- 12.3 Publisher Details
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
